COVID-19 Therapeutics Threshold Determinations by Jurisdiction

HHS/ASPR established threshold levels for ordering COVID-19 therapeutics available to each jurisdiction. The tables below are available for archival purposes only.

To find out how HHS/ASPR is currently bringing COVID-19 therapeutics to your state or territory, see COVID-19 Therapeutics Thresholds, Orders, and Replenishment by Jurisdiction.

Weekly COVID-19 Therapeutic Threshold Determinations January 30 - April 30, 2023

Weekly Threshold Determinations January 30 - April 30, 2023	Paxlovid (nirmatrelvir co-packaged with ritonavir; standard and reduced dose)	Lagevrio (molnupiravir)	Total
April 24 - April 30, 2023	612,165	48,604	660,769
April 17 - April 23, 2023	612,165	48,604	660,769
April 10 - April 16, 2023	612,165	48,604	660,769
April 3 - April 9, 2023	613,705	49,099	662,804
March 27 - April 2, 2023	612,165	48,604	660,769
March 20 - March 26, 2023	612,165	48,604	660,769
March 13 - March 19, 2023	612,165	48,604	660,769
March 6 - March 12, 2023	612,165	48,604	660,769
February 27 - March 5, 2023	613,705	49,099	662,804
February 20 - February 26, 2023	612,165	48,604	660,769
February 13 - February 19, 2023	612,165	48,604	660,769
February 6 - February 12, 2023	612,115	48,296	660,411
January 30 - February 5, 2023	613,655	48,791	662,446

Weekly COVID-19 Therapeutic Threshold Determinations September 5, 2022 - January 29, 2023

	Paxlovid (Standard and reduced dose)	Lagevrio (molnupiravir)	Evusheld	Total
January 23 - January 29, 2023	612,115	48,296	0	660,411
January 16 - January 22, 2023	612,115	48,296	0	660,411
January 9 - January 15, 2023	612,060	48,240	0	660,300
January 2 - January 8, 2023	613,580	48,735	204,096	866,411
December 26, 2022 - January 1, 2023	612,060	48,240	0	660,300
December 19 - December 25, 2022	612,060	48,240	0	660,300
December 12 - December 18, 2022	612,060	48,240	0	660,300
December 5 - December 11, 2022	613,580	48,735	204,096	866,411
November 28 - December 4, 2022	612,060	48,240	0	660,300
November 21 - November 27, 2022	612,060	48,240	0	660,300
November 14 - November 20, 2022	612,060	48,240	0	660,300
November 7 - November 13, 2022	612,060	48,240	0	660,300
October 31 - November 6, 2022	613,580	48,735	204,096	866,411
October 24 - October 30, 2022	612,060	48,240	0	660,300
October 17 - October 23, 2022	612,060	48,240	0	660,300
October 10 - October 16, 2022	612,060	48,240	0	660,300
October 3 - October 9, 2022	613,580	48,735	204,096	866,411
September 26 - October 2, 2022	612,060	48,312	0	660,372
September 19 - September 25, 2022	612,060	91,920	0	703,980
September 12 - September 18, 2022	612,060	91,920	0	703,980
September 5 - September 11, 2022	612,060	91,920	0	703,980

Weekly COVID-19 Therapeutic Threshold Determinations April 25, 2022 – September 6, 2022

	Paxlovid (Standard and Renal)	Lagevrio (molnupiravir)	Bebtelovimab	Evusheld	Total
September 6, 2022: Bebtelovimab Final Allocation	-	-	19,500	-	19,500
August 29-September 4, 2022	613,580	92,352	0	203,736	909,668
August 22-August 28, 2022	612,060	91,920	21,915	0	725,895
August 15-August 21, 2022	612,060	91,920	29,060	0	733,040
August 8-August 14, 2022	612,060	91,896	29,110	0	733,066
August 1-August 7, 2022	612,260	92,328	29,760	203,760	938,108
July 25-July 31, 2022	610,340	91,896	29,190	0	731,426
July 18-July 24, 2022	642,695	113,368	29,250	0	785,313
July 11-July 17, 2022	596,955	114,400	29,200	0	740,555
July 4-July 10, 2022	575,715	114,856	29,210	0	719,781
June 27-July 3, 2022	590,085	114,576	28,710	201,168	934,539
June 20-June 26, 2022	579,120	109,896	28,985	0	718,001
June 13-June 19, 2022	405,084	71,664	29,060	0	505,808
June 6-June 12, 2022	444,225	92,828	29,140	240	566,433
May 30-June 5, 2022	459,638	100,820	29,630	200,808	790,896
May 23-May 29, 2022	473,106	115,960	29,100	0	618,166
May 16-May 22, 2022	463,417	105,036	29,040	0	597,493
May 9-May 15, 2022	386,965	107,208	29,110	0	523,283
May 2-May 8, 2022	348,160	108,920	29,000	199,992	686,072
April 25-May 1, 2022	386,700	177,120	30,000	0	593,820

Prior COVID-19 Therapeutic Product Efforts